Brief: Enlivex Increases Previously Announced Bought Deal Offering To Approximately $46.0 Mln Of Ordinary Shares
10/02/2021 04:28
Feb 9 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX INCREASES PREVIOUSLY ANNOUNCED BOUGHT DEAL
OFFERING TO
APPROXIMATELY $46.0 MILLION OF ORDINARY SHARES
* ENLIVEX THERAPEUTICS - UNDERWRITER AGREED TO INCREASE SIZE
OF
OFFERING, PURCHASE ON A FIRM COMMITMENT BASIS 2,296,107 ORDINARY
SHARES AT $20 PER SHARE
Source text for Eikon: ID:nGNX2G3zdb
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment